Please use this identifier to cite or link to this item:
https://idr.l1.nitk.ac.in/jspui/handle/123456789/13209
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chandrakantha, B. | |
dc.contributor.author | Isloor, A.M. | |
dc.contributor.author | Shetty, P. | |
dc.contributor.author | Fun, H.K. | |
dc.contributor.author | Hegde, G. | |
dc.date.accessioned | 2020-03-31T08:45:23Z | - |
dc.date.available | 2020-03-31T08:45:23Z | - |
dc.date.issued | 2014 | |
dc.identifier.citation | European Journal of Medicinal Chemistry, 2014, Vol.71, , pp.316-323 | en_US |
dc.identifier.uri | http://idr.nitk.ac.in/jspui/handle/123456789/13209 | - |
dc.description.abstract | A new series of N-[5-(4-(alkyl/aryl)-3-nitro-phenyl)-[1,3,4-thiadiazol-2- yl]-2,2-dimethyl-propionamide 4 (a-l) and 6-(4-Methoxy-phenyl)-2-(4-alkyl/aryl)- 3-nitro-phenyl)-Imidazo [2,1-b] [1,3,4] thiadiazole 6 (a-l) were synthesized starting from 5-(4-Fluoro-3-nitro-phenyl)-[1,3,4] thiadiazole-2-ylamine. The synthesized compounds were characterized by IR, NMR, mass spectral and elemental analysis. All the compounds were tested for antibacterial and antifungal activities. The antimicrobial activities of the compounds were assessed by well plate method (zone of inhibition). Compounds 4a, 4c and 6e, 6g displayed appreciable activity at the concentration 0.5-1.0 mg/mL. 2013 Elsevier Masson SAS. All rights reserved. | en_US |
dc.title | Synthesis and biological evaluation of novel substituted 1,3,4-thiadiazole and 2,6-di aryl substituted imidazo [2,1-b] [1,3,4] thiadiazole derivatives | en_US |
dc.type | Article | en_US |
Appears in Collections: | 1. Journal Articles |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.